My Treatment Approach: Graft vs Host Disease : Episode 5
Investigational Systemic Treatment Options for GVHD
Nelson J. Chao, MD, MBA, details some novel agents being developed for the systemic treatment of GVHD, particularly chronic GVHD.
EP: 1.Patient Profile Presentation: A 60-Year-Old Man with Graft-Versus-Host Disease (GVHD)
EP: 2.Staging of Chronic GVHD
EP: 3.First-Line Treatment Options for Patients with Chronic GVHD
EP: 4.Patient Profile Presentation: A 67-Year-Old Woman with GVHD
Now Viewing
EP: 5.Investigational Systemic Treatment Options for GVHD
EP: 6.Treatment Sequencing and Future of GVHD
EP: 7.Patient Profile Presentation: A 44-Year-Old Woman With Acute Myeloid Leukemia and Graft-Versus-Host Disease (GVHD)
EP: 8.Indications for Allogeneic Stem Cell Transplantation in the Treatment of Myeloid Malignancies
EP: 9.Tailored Conditioning Regimens for Patients with GVHD Receiving Allogeneic Transplant
EP: 10.Currently Available Options for GVHD Prophylaxis
EP: 11.Comparing Acute and Chronic GVHD
EP: 12.Available Frontline Treatment Options for Patients With Acute GVHD
EP: 13.Current Treatment Options for Patients with Steroid-Refractory Acute GVHD
Related Videos
Related Content
